Milestone Pharmaceuticals Inc. - Common Shares, no par value (MIST)

CUSIP: 59935V107

Q3 2022 13F Holders as of 30 Sep 2022

Holder snapshot 7 signals
Share change
+496,568
Put/Call ratio
71%
SEC-reported price per share
$9.19
Number of holders
43
Value change
+$10,127,011
Number of buys
24
Open additional details 1 more signal available
Number of sells
15
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
124,217,096

Security key

59935V107

Report period

Q3 2022

Institutions

43

Top holders

10

Ownership snapshot

Top reported holders of MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RTW INVESTMENTS, LP
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
0/15
Latest evidence
30 Jun 2022
13F Highest disclosed value: $26,538,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

RTW INVESTMENTS, LP has the largest disclosed position value at $26.54M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RTW INVESTMENTS, LP's linked filing trail.
Disclosed position value Top 5
RTW INVESTMENTS, LP $26.54M
Novo Holdings A/S $15.56M
RA CAPITAL MANAGEMENT, L.P. $13.82M
Boxer Capital, LLC $13.77M
ORBIMED ADVISORS LLC $11.18M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RTW INVESTMENTS, LP
13F
Company
13F
—
denominator unverified
$26,538,000
4,315,102 shares
— 30 Jun 2022
Novo Holdings A/S
13F
Company
13F
—
denominator unverified
$15,560,000
2,530,003 shares
— 30 Jun 2022
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$13,816,000
2,246,503 shares
— 30 Jun 2022
Boxer Capital, LLC
13F
Company
13F
—
denominator unverified
$13,769,000
2,238,861 shares
— 30 Jun 2022
ORBIMED ADVISORS LLC
13F
Company
13F
—
denominator unverified
$11,178,000
1,817,521 shares
— 30 Jun 2022
Ikarian Capital, LLC
13F
Company
13F
—
denominator unverified
$8,194,000
1,379,422 shares
— 30 Jun 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
43
Shares
20,398,285
Rows available
43
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
29
Q3 2022 holders
43
Holder diff
14
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 value Q3 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .